Optic Neuritis
What's New
Last Posted: Jan 18, 2024
- Optic Neuritis: The Influence of Gene Polymorphisms and Serum Levels of STAT4 (rs10181656, rs7574865, rs7601754, rs10168266).
Greta Gedvilaite, et al. Journal of clinical medicine 2024 0 (1) - Association of retinal vessel pathology and brain atrophy in relapsing-remitting multiple sclerosis.
Eva Feodora Romahn, et al. Frontiers in immunology 2023 0 1284986 - The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis.
Kubiliute Aleksandra, et al. Orphanet journal of rare diseases 2023 0 (1) 64 - Mendelian randomization analysis reveals causal relationships between gut microbiome and optic neuritis.
Liu Kangcheng, et al. Human genetics 2022 0 - A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis.
Zhao Xiujuan, et al. BMC ophthalmology 2018 0 (1) 247 - Association of MMP-2 (?1306 C/T) Gene Polymorphism with Predisposition to Optic Neuritis and Optic Neuritis Together with Multiple Sclerosis.
Liutkevi?ien? Rasa, et al. Medicina (Kaunas, Lithuania) 2018 0 (2) - Does CETP rs5882, rs708272, SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, VEGFA rs833068, IL6 rs1800795 polymorphisms play a role in optic neuritis development?
Gedvilaite Greta, et al. Ophthalmic genetics 2019 0 (3) 219-226 - Association of VEGFA, TIMP-3, and IL-6 gene polymorphisms with predisposition to optic neuritis and optic neuritis with multiple sclerosis.
Punyte Vaida, et al. Ophthalmic genetics 2020 0 (1) 35-44 - Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants.
Mulazzani Elisabeth, et al. Journal of neuroinflammation 2020 0 (1) 196 - Ocular inflammatory diseases in children with familial Mediterranean fever: a true association or a coincidence?
Avar-Aydin Pinar Ozge, et al. International ophthalmology 2021 0 (4) 1249-1257 - Leber's hereditary optic neuropathy companied with multiple-related diseases.
Sun Ming-Ming, et al. Frontiers in human neuroscience 2022 0 964550 - ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Dai Yuyang, et al. Journal of clinical pharmacy and therapeutics 2022 0 (9) 1379-1387 - Screening for mt-DNA mutations in optic neuritis of unknown cause.
Guo L, et al. Chinese medical journal 2002 0 (7) 640-2 - Association of HLA DRB1-DQB1 Haplotypes with the Risk for Neuromyelitis Optica among South Indians.
Kanikannan Meena A, et al. Neurology India 0 0 (4) 1481-1486 - Association of RAGE rs1800624 and rs1800625 gene polymorphisms with predisposition to optic neuritis and optic neuritis together with multiple sclerosis.
Kolonaite Gabriele, et al. Ophthalmic genetics 2021 8 1-6 - Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patients.
Liu Lanzhi, et al. Multiple sclerosis and related disorders 2021 1 102779 - HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.
Watanabe Mitsuru, et al. Scientific reports 2021 1 (1) 607 - Associations between IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, and HTRA1 rs11200638 gene polymorphisms and development of optic neuritis with or without multiple sclerosis.
Stonys Valdas, et al. Ophthalmic genetics 2020 5 1-6 - Early complement genes are associated with visual system degeneration in multiple sclerosis.
Fitzgerald Kathryn C, et al. Brain : a journal of neurology 2019 9 (9) 2722-2736 - Association Between BDNF Val66Met Polymorphism and Optic Neuritis Damage in Neuromyelitis Optica Spectrum Disorder.
Shen Ting, et al. Frontiers in neuroscience 2019 0 1236
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: